CB vs COYA · P/E 14, rev $59.40B vs rev $3.6M
Chubb Ltd (CB) versus Coya Therapeutics, Inc. Common Stock (COYA) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported COYA revenue for 2024-12-31 was $3.6M. Net income was -$14.9M. Revenue was down 40.8% from 2023-12-31 to 2024-12-31. COYA currently screens at market cap $118.0M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. COYA currently screens at market cap $118.0M.
Not investment advice. Open the CB and COYA stock pages for the full models.
Not investment advice.